A 277: Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.*
Approved P.L.2021, c.285.
Sponsors
Shirley Turner
(D)
,
John Armato
(D)
,
Troy Singleton
(D)
,
Robert Karabinchak
(D)
· 2 co-sponsors